Annual report [Section 13 and 15(d), not S-K Item 405]

Concentrations

v3.25.0.1
Concentrations
12 Months Ended
Dec. 31, 2024
Risks and Uncertainties [Abstract]  
Concentrations

Note L - Concentrations

Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the year ended December 31, 2024 and 2023. In 2024, one party constituted 100% of the Company’s revenue and in 2023 four parties constituted 90% of the Company’s revenue.